Sharp Edge

is a drug discovery company that develops a biosensor platform to detect cellular protein trafficking for the treatment of genetic disorders...
Read more
Sharp Edge President & CEO: Scott F Sneddon

President & CEO

Scott F Sneddon

CEO Approval Rating

83/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$7.1M

Sharp Edge Competitors

1bluebird bio
2Regenxbio
3Spark Therapeutics
4Intellia
5Sangamo
6Homology
7CRISPR
84DMT
9Novartis
10Adverum

Trending Companies